These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 5519088

  • 1. [Differential diagnosis of headache and experiences with a new preparation in the treatment of migraine].
    Brügger A.
    Schweiz Rundsch Med Prax; 1970 Sep 29; 59(39):1360-5. PubMed ID: 5519088
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new agent for chemotherapy of migraine headaches: a controlled study.
    Krakowski AJ, Engisch R.
    Psychosomatics; 1973 Sep 29; 14(5):302-8. PubMed ID: 4604015
    [No Abstract] [Full Text] [Related]

  • 6. [Sandomigrin (pizotiphenum NFN) in migraine prevention].
    Jorgensen RS.
    Ugeskr Laeger; 1973 Nov 12; 135(46):2528. PubMed ID: 4781855
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Horton's headaches treated with sandomigran (BC-105)].
    Prusiński A, Klimek A.
    Wiad Lek; 1973 Feb 15; 26(4):367-72. PubMed ID: 4688825
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Zung's test for the quantitative assessment of depression and its confirmation during the testing of a new anti-migraine agent Sandomigran].
    Klapetek J.
    Cesk Neurol; 1973 Sep 15; 36(5):298-303. PubMed ID: 4581588
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of BC 105 on the depressed mood in migraine].
    Müller KH, Haarmann K, Neff K.
    Ther Umsch; 1972 Oct 15; 29(10):628-35. PubMed ID: 5078775
    [No Abstract] [Full Text] [Related]

  • 13. [BC 105 in migraine].
    Poch GF.
    Prensa Med Argent; 1972 May 12; 59(15):563-7. PubMed ID: 4403208
    [No Abstract] [Full Text] [Related]

  • 14. Clinical physiological study of the action of BC 105 (Sandoz, Basle) in the interval therapy of migraine.
    Starý O, Janský M, Figar S, Stein J.
    Eur Neurol; 1974 May 12; 11(6):353-62. PubMed ID: 4604231
    [No Abstract] [Full Text] [Related]

  • 15. [Sandomigrin in migraine therapy].
    Stensrud P, Sjaastad O.
    Tidsskr Nor Laegeforen; 1972 Dec 30; 92(35):2443-4. PubMed ID: 4657023
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Zung's test for the quantitative assessment of depression and its confirmation through the testing of a new anti-migraine drug Sandomigran].
    Klapetek J.
    Cesk Neurol Neurochir; 1973 Oct 30; 36(5):298-303. PubMed ID: 4588664
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical experiences with polyantiaminic BC-105 Sandoz in the prevention of vasomotor headaches].
    Sercl M, Vrcha L.
    Schweiz Rundsch Med Prax; 1970 May 05; 59(18):679-83. PubMed ID: 4396441
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.